Table 1 Baseline demographic and clinical characteristics by relapse frequency and payor type.
Patient Characteristics | Commercial | Medicare | Medicaid | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 Relapses | 1 Relapse | ≥2 Relapses | Overall | 0 Relapses | 1 Relapse | ≥2 Relapses | Overall | 0 Relapses | 1 Relapse | ≥2 Relapses | Overall | |
Number of patients, N | 3726 | 828 | 420 | 4974 | 1178 | 268 | 214 | 1660 | 3048 | 942 | 868 | 4858 |
Demographics | ||||||||||||
Age on index (years), mean (SD) | 33.5 (14.67) | 30.3 (13.04) | 29.4 (12.45) | 32.6 (14.30) | 56.6 (13.47) | 52.3 (11.92) | 49.9 (11.74) | 55.0 (13.30) | 34.9 (14.75) | 34.5 (13.62) | 34.8 (12.11) | 34.8 (14.10) |
12–17 | 353 (9.5%) | 57 (6.9%) | 40 (9.5%) | 450 (9.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 494 (16.2%) | 122 (13.0%) | 61 (7.0%) | 677 (13.9%) |
18–44 | 2359 (63.3%) | 607 (73.3%) | 311 (74.0%) | 3277 (65.9%) | 219 (18.6%) | 69 (25.7%) | 68 (31.8%) | 356 (21.4%) | 1675 (55.0%) | 568 (60.3%) | 592 (68.2%) | 2835 (58.4%) |
45+ | 1014 (27.2%) | 164 (19.8%) | 69 (16.4%) | 1247 (25.1%) | 959 (81.4%) | 199 (74.3%) | 146 (68.2%) | 1,304 (78.6%) | 879 (28.8%) | 252 (26.8%) | 215 (24.8%) | 1346 (27.7%) |
Female, n (%) | 1644 (44.1%) | 328 (39.6%) | 199 (47.4%) | 2171 (43.6%) | 583 (49.5%) | 129 (48.1%) | 113 (52.8%) | 825 (49.7%) | 1561 (51.2%) | 521 (55.3%) | 446 (51.4%) | 2528 (52.0%) |
Geographic region of patient,a n (%) | ||||||||||||
Northeast | 490 (13.2%) | 136 (16.4%) | 63 (15.0%) | 689 (13.9%) | 239 (20.3%) | 55 (20.5%) | 35 (16.4%) | 329 (19.8%) | 0 (0%) | 0 (0%) | 0 (0%) | (0.0%) |
Midwest | 874 (23.5%) | 179 (21.6%) | 82 (19.5%) | 1,135 (22.8%) | 511 (43.4%) | 140 (52.2%) | 99 (46.3%) | 750 (45.2%) | 0 (0%) | 0 (0%) | 0 (0%) | (0.0%) |
South | 1196 (32.1%) | 268 (32.4%) | 128 (30.5%) | 1,592 (32.0%) | 222 (18.8%) | 53 (19.8%) | 45 (21.0%) | 320 (19.3%) | 2,334 (76.6%) | 735 (78.0%) | 636 (73.3%) | 3,705 (76.3%) |
West | 1058 (28.4%) | 218 (26.3%) | 132 (31.4%) | 1,408 (28.3%) | 206 (17.5%) | 20 (7.5%) | 35 (16.4%) | 261 (15.7%) | 714 (23.4%) | 207 (22.0%) | 232 (26.7%) | 1153 (23.7%) |
Rural/urban designation,a n (%) | ||||||||||||
Rural | 972 (26.1%) | 213 (25.7%) | 106 (25.2%) | 1,291 (26.0%) | 215 (18.3%) | 47 (17.5%) | 38 (17.8%) | 300 (18.1%) | 511 (16.8%) | 156 (16.6%) | 140 (16.1%) | 807 (16.6%) |
Urban | 2719 (73.0%) | 606 (73.2%) | 312 (74.3%) | 3,637 (73.1%) | 962 (81.7%) | 221 (82.5%) | 176 (82.2%) | 1,359 (81.9%) | 2,537 (83.2%) | 786 (83.4%) | 728 (83.9%) | 4,051 (83.4%) |
Year of index date, n (%) | ||||||||||||
2014 | 590 (15.8%) | 158 (19.1%) | 78 (18.6%) | 826 (16.6%) | 146 (12.4%) | 37 (13.8%) | 29 (13.6%) | 212 (12.8%) | 202 (6.6%) | 69 (7.3%) | 87 (10.0%) | 358 (7.4%) |
2015 | 602 (16.2%) | 129 (15.6%) | 78 (18.6%) | 809 (16.3%) | 123 (10.4%) | 33 (12.3%) | 11 (5.1%) | 167 (10.1%) | 330 (10.8%) | 108 (11.5%) | 102 (11.8%) | 540 (11.1%) |
2016 | 630 (16.9%) | 143 (17.3%) | 62 (14.8%) | 835 (16.8%) | 147 (12.5%) | 41 (15.3%) | 30 (14.0%) | 218 (13.1%) | 422 (13.8%) | 122 (13.0%) | 86 (9.9%) | 630 (13.0%) |
2017 | 558 (15.0%) | 134 (16.2%) | 61 (14.5%) | 753 (15.1%) | 168 (14.3%) | 39 (14.6%) | 37 (17.3%) | 244 (14.7%) | 343 (11.3%) | 125 (13.3%) | 108 (12.4%) | 576 (11.9%) |
2018 | 508 (13.6%) | 97 (11.7%) | 59 (14.0%) | 664 (13.3%) | 180 (15.3%) | 25 (9.3%) | 34 (15.9%) | 239 (14.4%) | 437 (14.3%) | 173 (18.4%) | 140 (16.1%) | 750 (15.4%) |
2019 | 535 (14.4%) | 101 (12.2%) | 51 (12.1%) | 687 (13.8%) | 263 (22.3%) | 57 (21.3%) | 52 (24.3%) | 372 (22.4%) | 728 (23.9%) | 191 (20.3%) | 210 (24.2%) | 1129 (23.2%) |
2020b | 303 (8.1%) | 66 (8.0%) | 31 (7.4%) | 400 (8.0%) | 151 (12.8%) | 36 (13.4%) | 21 (9.8%) | 208 (12.5%) | 586 (19.2%) | 154 (16.3%) | 135 (15.6%) | 875 (18.0%) |
Social determinants of health (SDoH) – census block group level | ||||||||||||
Median family income in past 12 months, mean (SD) | $86,898 ($44,947) | $87,926 ($45,557) | $89,040 ($45,164) | $87,250 ($45,063) | $75,380 ($39,589) | $70,335 ($43,652) | $71,782 ($40,760) | $74,102 ($40,448) | $63,903 ($33,134) | $58,922 ($31,090) | $58,979 ($31,247) | $62,057 ($32,497) |
Proportion of population who are non-Hispanic black, mean (SD) | 0.11 (0.20) | 0.11 (0.20) | 0.10 (0.17) | 0.10 (0.20) | 0.17 (0.26) | 0.20 (0.28) | 0.18 (0.27) | 0.20 (0.30) | 0.36 (0.32) | 0.39 (0.33) | 0.36 (0.32) | 0.40 (0.30) |
Proportion of population who are Hispanic/Latino, mean (SD) | 0.12 (0.18) | 0.12 (0.18) | 0.13 (0.19) | 0.10 (0.20) | 0.13 (0.20) | 0.11 (0.19) | 0.11 (0.18) | 0.10 (0.20) | 0.13 (0.17) | 0.13 (0.18) | 0.14 (0.19) | 0.10 (0.20) |
Quartiles of socioeconomic status (SES),a,c n (%) | ||||||||||||
1 (Low SES) | 615 (16.5%) | 144 (17.4%) | 64 (15.2%) | 823 (16.5%) | 296 (25.1%) | 86 (32.1%) | 76 (35.5%) | 458 (27.6%) | 1265 (41.5%) | 435 (46.2%) | 398 (45.9%) | 2098 (43.2%) |
2 | 767 (20.6%) | 158 (19.1%) | 74 (17.6%) | 999 (20.1%) | 292 (24.8%) | 72 (26.9%) | 48 (22.4%) | 412 (24.8%) | 771 (25.3%) | 229 (24.3%) | 207 (23.8%) | 1207 (24.8%) |
3 | 938 (25.2%) | 211 (25.5%) | 98 (23.3%) | 1,247 (25.1%) | 299 (25.4%) | 55 (20.5%) | 45 (21.0%) | 399 (24.0%) | 484 (15.9%) | 128 (13.6%) | 135 (15.6%) | 747 (15.4%) |
4 (High SES) | 1323 (35.5%) | 299 (36.1%) | 172 (41.0%) | 1794 (36.1%) | 256 (21.7%) | 47 (17.5%) | 43 (20.1%) | 346 (20.8%) | 333 (10.9%) | 60 (6.4%) | 54 (6.2%) | 447 (9.2%) |
Clinical characteristic and comorbidities | ||||||||||||
Quan-Charlson comorbidity index (QCI), mean (SD) | 0.3 (0.88) | 0.3 (0.78) | 0.5 (1.07) | 0.3 (0.90) | 1.0 (1.59) | 1.0 (1.44) | 1.2 (1.67) | 1.0 (1.60) | 0.5 (1.06) | 0.6 (1.13) | 0.8 (1.52) | 0.6 (1.20) |
Asthma | 298 (8.0%) | 84 (10.1%) | 65 (15.5%) | 447 (9.0%) | 119 (10.1%) | 53 (19.8%) | 52 (24.3%) | 224 (13.5%) | 407 (13.4%) | 158 (16.8%) | 173 (19.9%) | 738 (15.2%) |
Dyslipidemia | 580 (15.6%) | 118 (14.3%) | 59 (14.0%) | 757 (15.2%) | 531 (45.1%) | 113 (42.2%) | 104 (48.6%) | 748 (45.1%) | 512 (16.8%) | 168 (17.8%) | 150 (17.3%) | 830 (17.1%) |
Hypertension | 612 (16.4%) | 139 (16.8%) | 79 (18.8%) | 830 (16.7%) | 595 (50.5%) | 144 (53.7%) | 108 (50.5%) | 847 (51.0%) | 805 (26.4%) | 278 (29.5%) | 310 (35.7%) | 1393 (28.7%) |
Overweight/obesity | 497 (13.3%) | 94 (11.4%) | 75 (17.9%) | 666 (13.4%) | 294 (25.0%) | 77 (28.7%) | 67 (31.3%) | 438 (26.4%) | 576 (18.9%) | 197 (20.9%) | 205 (23.6%) | 978 (20.1%) |
Behavioral health comorbidities, n (%) | ||||||||||||
Alcohol use disorder | 299 (8.0%) | 121 (14.6%) | 68 (16.2%) | 488 (9.8%) | 71 (6.0%) | 30 (11.2%) | 37 (17.3%) | 138 (8.3%) | 260 (8.5%) | 124 (13.2%) | 195 (22.5%) | 579 (11.9%) |
Anxiety disorders | 1523 (40.9%) | 361 (43.6%) | 232 (55.2%) | 2116 (42.5%) | 328 (27.8%) | 101 (37.7%) | 100 (46.7%) | 529 (31.9%) | 1000 (32.8%) | 386 (41.0%) | 453 (52.2%) | 1839 (37.9%) |
Attention-deficit/hyperactivity disorder | 478 (12.8%) | 134 (16.2%) | 82 (19.5%) | 694 (14.0%) | 39 (3.3%) | ≤10 | ≤10 | 57 (3.4%) | 448 (14.7%) | 130 (13.8%) | 117 (13.5%) | 695 (14.3%) |
Bipolar disorder | 1020 (27.4%) | 274 (33.1%) | 187 (44.5%) | 1481 (29.8%) | 314 (26.7%) | 102 (38.1%) | 107 (50.0%) | 523 (31.5%) | 883 (29.0%) | 383 (40.7%) | 417 (48.0%) | 1683 (34.6%) |
Depression | 1532 (41.1%) | 373 (45.0%) | 237 (56.4%) | 2142 (43.1%) | 399 (33.9%) | 101 (37.7%) | 103 (48.1%) | 603 (36.3%) | 1231 (40.4%) | 437 (46.4%) | 470 (54.1%) | 2138 (44.0%) |
Emotional disturbance | 67 (1.8%) | 18 (2.2%) | 21 (0.5%) | 106 (2.1%) | ≤10 | ≤10 | ≤10 | 15 (0.9%) | 55 (1.8%) | 21 (2.2%) | 26 (3.0%) | 102 (2.1%) |
Intellectual disability | 37 (1.0%) | ≤10 | ≤10 | 54 (1.1%) | 29 (2.5%) | ≤10 | ≤10 | 43 (2.6%) | 96 (3.1%) | 22 (2.3%) | 29 (3.3%) | 147 (3.0%) |
Learning disability | 18 (0.5%) | ≤10 | ≤10 | 27 (0.5%) | ≤10 | ≤10 | 0 (0.0%) | ≤10 | 30 (1.0%) | ≤10 | ≤10 | 42 (0.9%) |
Nicotine dependence | 552 (14.8%) | 211 (25.5%) | 144 (34.3%) | 907 (18.2%) | 269 (22.8%) | 101 (37.7%) | 101 (47.2%) | 471 (28.4%) | 911 (29.9%) | 364 (38.6%) | 511 (58.9%) | 1786 (36.8%) |
Personality disorder | 173 (4.6%) | 58 (7.0%) | 55 (13.1%) | 286 (5.7%) | 36 (3.1%) | 20 (7.5%) | 27 (12.6%) | 83 (5.0%) | 120 (3.9%) | 65 (6.9%) | 75 (8.6%) | 260 (5.4%) |
Post traumatic stress disorder | 71 (1.9%) | 22 (2.7%) | 32 (7.6%) | 125 (2.5%) | 14 (1.2%) | ≤10 | ≤10 | 28 (1.7%) | 48 (1.6%) | 17 (1.8%) | 32 (3.7%) | 97 (2.0%) |
Substance use disorderd | 664 (17.8%) | 227 (27.4%) | 140 (33.3%) | 1,031 (20.7%) | 129 (11.0%) | 44 (16.4%) | 62 (29.0%) | 235 (14.2%) | 623 (20.4%) | 318 (33.8%) | 417 (48.0%) | 1358 (28.0%) |
Suicidal attempts/injuries related to intentional self-harm | 75 (2.0%) | 20 (2.4%) | 25 (6.0%) | 120 (2.4%) | 14 (1.2%) | ≤10 | ≤10 | 26 (1.6%) | 47 (1.5%) | 41 (4.4%) | 46 (5.3%) | 134 (2.8%) |
Suicidal ideation | 456 (12.2%) | 157 (19.0%) | 128 (30.5%) | 741 (14.9%) | 60 (5.1%) | 35 (13.1%) | 45 (21.0%) | 140 (8.4%) | 391 (12.8%) | 211 (22.4%) | 264 (30.4%) | 866 (17.8%) |